Antistreptokinase antibodies before and after streptokinase therapy in patients with acute myocardial infarction from areas endemic for streptococcal infection and influence on reperfusion rates
- 1 July 1994
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 74 (2) , 187-189
- https://doi.org/10.1016/0002-9149(94)90099-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Angiographic validation of bedside markers of reperfusionJournal of the American College of Cardiology, 1993
- Streptokinase resistance: when might streptokinase administration be ineffective?Heart, 1992
- Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarctionAmerican Heart Journal, 1992
- Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.Heart, 1991
- Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilizing the combined analysis of three noninvasive markersJournal of the American College of Cardiology, 1991
- Antistreptokinase titres after intravenous streptokinaseThe Lancet, 1990
- Significance of antibodies to streptokinase in coronary thrombolytic therapy with streptokinase or APSACFibrinolysis, 1988
- Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker.Heart, 1988
- Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: Correlation with acute angiographyJournal of the American College of Cardiology, 1988
- Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibodyJournal of the American College of Cardiology, 1984